Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals

European Journal of Pharmacology

Volumn 274, Issue 1-3, 1995, Pages 65-72

  Kinoshita, Kiyoshi ^a   Fujitsuka, Tatsuya ^a   Yamamura, Michio ^a   Matsuoka, Yuzo ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Ataxia; Oral administration; TA 0910 (TRH analog); TRH (thyrotropin releasing hormone)

Indexed keywords

3 ACETYLPYRIDINE; PROTIRELIN; PROTIRELIN DERIVATIVE; TALTIRELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATAXIA; BRAIN INJURY; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG POTENCY; FEMALE; GAIT; GENETIC DISORDER; INFERIOR OLIVE; MALE; MECHANICAL STRESS; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; THORACIC SPINAL CORD;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMALS; ATAXIA; CEREBELLUM; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GAIT; INFERIOR COLLICULUS; MALE; MICE; MICE, NEUROLOGIC MUTANTS; PYRIDINES; RATS; RATS, WISTAR; SPINAL CORD COMPRESSION; THORACIC VERTEBRAE; THYROTROPIN-RELEASING HORMONE;

EID: 0028966061     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(94)00712-G     Document Type: Article

References (34)

1. Trophic effect of thyrotropin-releasing hormone on murine ventral horn neurons in culture
2. Trophic effect of thyrotropin-releasing hormone on neuronal processes in culture
3. Thyrotropin-releasing hormone decreases neuronal loss induced by axotomy in infant rats
4. Metabolism and Excretion of exogenous thyrotropin-releasing hormone in humans
5. A summary of the current position of TRH in ALS therapy
6. Effects of 3-acetylpyridine on the central nervous system of the rat, as demonstrated by silver method
7. Thyrotropin-releasing hormone improves neurologic recovery after spinal trauma in cats
8. Thyrotropin-releasing hormone in experimental spinal injury: Dose response and late treatment
9. Change in TRH immunoreactivity in spinal cord after experimental spinal injury
10. Neurochemical study of TA-0910, a new TRH analog (1): effect on monoamine metabolism in rat brain
11. Effect of thyrotropin-releasing hormone on the time course of neurologic recovery after spinal cord injury in the rat
12. Pharmacology of thyrotropin-releasing hormone
13. TRH analogue, TA-0910 (3-methyl-(s)-5,6-dihydroorotyl-l-histidyl-l-prolinamide) enhances neurite outgrowth in rat embryo ventral spinal cord in vitro
14. Thyrotropin-releasing hormone (TRH) in rat spinal cord
15. Noradrenaline metabolism in the brain of Rolling mouse Nagoya and the influence of thyrotropin releasing hormone
16. Histydyl-proline diketopiperazine (HPD), a metabolite of thyrotropin-releasing hormone (TRH), improves the ataxic gait in 3-acetylpyridine (3-AP) treated rats
17. Effects of thyrotropin-releasing hormone tartrate (TRH-T) and its main metabolite Histidyl-Proline Diketopiperazine on the walking ataxia in Rolling mouse Nagoya
18. Inferior olive: Its role in motor learning
19. Regulatory peptides as a source of new drugs: The clinical prospects for analogues of TRH which are resistant to metabolic degeneration
20. Neurotransmitter abnormality in Rolling mouse Nagoya, an ataxic mutant mouse
21. Central noradrenaline metabolism in cerebellar ataxic mice
22. The cerebellum of rolling mouse Nagoya
23. Distribution and concentration of TRH in the rat brain
24. Depressant action of TRH, LH-RH and somatostatin on activity of central neurons
25. Spinal cord immunoreactive TRH is altered after local traumatic injury
26. On the Purkinje cell activity increase induced by suppression of inferior olive activity
27. TRH therapy of ataxia in patients with SCD
28. Temporal sequence of motor disturbances and increased cerebellar glutamic acid decarboxylase activity following 3-acetylpyridine lesions in adult rats
29. Synthesis and central nervous system actions of thyrotropin-releasing hormone analogues containing a dihydroorotic acid moiety
30. Rolling mouse Nagoya as a mutant animal model of basal ganglia dysfunction: determination of absolute rates of local cerebral glucose utilization
31. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog, (1): effects on the central nervous system by oral administration
32. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (2): involvement of the DA system in the locomotor stimulating action of TA-0910
33. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (3): inhibition of pentobarbital anesthesia
34. Absorption of thyrotropin-releasing hormone after oral administration of TRH tartrate monohydrate in the rat, dog and human